What we do

Pharmacy Rate Setting & Reimbursement


Pharmacy rate setting and reimbursement are critical to ensuring beneficiary access to medications, supporting pharmacy participation, and maintaining the financial integrity of Medicaid, Medicare, and other government-sponsored health care programs. Myers & Stauffer provides independent pharmacy reimbursement consulting and supports federal and state agencies with actual acquisition cost (AAC) programs, National Average Drug Acquisition Cost (NADAC) implementation, state maximum allowable cost (SMAC) methodologies, cost of dispensing (COD) surveys, 340B reimbursement oversight, and Medicaid managed care pharmacy reimbursement. Our expertise in pharmacy pricing, reimbursement methodology development, and pharmacy financial analysis helps agencies strengthen compliance, improve transparency, and develop sustainable reimbursement models that support responsible stewardship of public funds.

Happy pharmacist using laptop while her colleagues is taking notes in pharmacy.

Supporting Accurate, Transparent, and Sustainable Pharmacy Reimbursement

Pharmacy reimbursement methodologies directly influence beneficiary access, provider participation, program costs, and compliance with federal requirements. As pharmacy markets continue to evolve, government agencies must ensure reimbursement approaches accurately reflect acquisition costs, dispensing costs, and changing regulatory expectations.

Myers & Stauffer helps government agencies develop, evaluate, and maintain pharmacy reimbursement methodologies that promote transparency, financial accountability, and compliance across Medicaid fee-for-service, Medicaid managed care, and other government-sponsored health programs.

Our team brings extensive experience supporting state and federal agencies in pharmacy pricing, reimbursement analysis, financial modeling, and pharmacy program oversight.


Pharmacy Reimbursement Expertise

We support agencies through all aspects of pharmacy reimbursement design and evaluation, including:

  • Actual acquisition cost (AAC) programs.
  • State maximum allowable cost (SMAC) methodologies.
  • Cost of dispensing (COD) surveys.
  • Pharmacy reimbursement policy development.
  • Medicaid managed care reimbursement oversight.
  • 340B reimbursement monitoring and compliance.
  • National Average Drug Acquisition Cost (NADAC)-based reimbursement.
  • Pharmacy financial modeling and analytics.

Our work helps agencies establish reimbursement methodologies that are data-driven, defensible, and aligned with federal requirements.

Where We Support Pharmacy Rate Setting

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco

Accurate reimbursement begins with understanding the prices pharmacies pay to acquire prescription drugs.

We assist states with:

  • AAC survey design and implementation.
  • Data collection and validation.
  • Pricing methodology development.
  • Ongoing maintenance and updates.
  • Federal compliance support.

These programs help ensure reimbursement reflects current market conditions and pharmacy acquisition costs.

SMAC programs are a critical tool for managing generic drug reimbursement.

Our services include:

  • SMAC methodology design.
  • Pricing file development and maintenance.
  • Market price analysis.
  • Appeals process evaluation.
  • Compliance reviews and benchmarking.

We help agencies establish transparent and sustainable reimbursement methodologies for multisource drugs.

Myers and Stauffer has extensive experience supporting pharmacy pricing initiatives, including long-standing support of CMS’s National Average Drug Acquisition Cost (NADAC) program.

We assist agencies with:

  • NADAC implementation strategies.
  • Reimbursement methodology development.
  • Pricing analysis and benchmarking.
  • Financial impact assessments.
  • Pharmacy reimbursement evaluations.

Our experience helps agencies align reimbursement approaches with nationally recognized pricing benchmarks.

Professional dispensing fees remain a critical component of pharmacy reimbursement.

We conduct comprehensive cost of dispensing surveys that support:

  • Professional dispensing fee development.
  • Federal compliance requirements.
  • Reimbursement adequacy assessments.
  • Financial impact analysis.
  • Rate update initiatives.

Our methodologies provide agencies with objective data to support defensible reimbursement decisions.

340B programs create unique reimbursement and oversight considerations for Medicaid agencies.

We support agencies through:

  • 340B billing policy development.
  • Prospective reimbursement methodologies.
  • Estimated ceiling price implementation.
  • Claims analysis and validation.
  • Retrospective compliance reviews.

These efforts help states strengthen oversight while maintaining compliance with federal requirements.

As pharmacy benefits continue to evolve within managed care environments, states must maintain visibility into reimbursement practices applied by managed care organizations and their PBMs.

We assist agencies with:

  • Reimbursement methodology evaluations.
  • Managed care pharmacy payment reviews.
  • PBM reimbursement assessments.
  • Financial impact analyses.
  • Alignment of managed care and fee-for-service reimbursement strategies.

Our work supports consistent oversight across pharmacy delivery models.


Related Pharmacy Services

Pharmacy reimbursement and pharmacy benefit oversight are closely connected.

  • PBM oversight & audit.
  • Drug rebate program oversight.
  • Pharmacy program integrity.
  • Medicaid managed care oversight.
  • Medicare Part D oversight.
nationwide experience

Why Agencies Hire Myers & Stauffer

Experience & Approach

Our pharmacy reimbursement services combine financial expertise, pharmacy pricing knowledge, advanced analytics, and extensive government program experience.

We bring:

  • More than four decades of government health care consulting experience.
  • An independent perspective focused exclusively on government agencies.
  • Deep expertise in AAC, SMAC, NADAC, and COD methodologies.
  • Experience supporting CMS pharmacy reimbursement initiatives.
  • Advanced pharmacy claims and financial analytics capabilities.

We work closely with agencies to develop reimbursement methodologies that support access, accountability, and long-term program sustainability.

Supporting Effective Pharmacy Reimbursement

We help government agencies develop and maintain pharmacy reimbursement methodologies that are transparent, data-driven, and compliant with federal requirements. Our focus is on supporting sustainable pharmacy programs that balance access to care with responsible stewardship of public resources.

The Transformative Power of Partnership

Connect With Our Team

Partner with experts who understand the complexities of health and human services programs. Let us guide your organization through the industry’s unique challenges and opportunities.

Allan Hansen
Principal

Email: ahansen@mslc.com
Phone Number: 816-957-6230

In the Words of our Clients…

Myers & Stauffer is a trusted audit partner with extensive knowledge of Medicaid and Medicare programs and finances.  Their staff have high levels of professionalism and integrity and are reliable subject matter experts when it comes to Medicaid reimbursement.” 

Sharing Knowledge & strengthening programs

Recent Insights

We’re committed to advancing government health care through thought leadership, collaboration, and the open exchange of ideas that drive better outcomes. Explore our latest blogs, client alerts, case studies, and thought leadership to see how our expertise can support your goals.